These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 1599928)

  • 1. Channel-forming activity of the perforin N-terminus and a putative alpha-helical region homologous with complement C9.
    Persechini PM; Ojcius DM; Adeodato SC; Notaroberto PC; Daniel CB; Young JD
    Biochemistry; 1992 Jun; 31(21):5017-21. PubMed ID: 1599928
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytolytic and ion channel-forming properties of the N terminus of lymphocyte perforin.
    Ojcius DM; Persechini PM; Zheng LM; Notaroberto PC; Adeodato SC; Young JD
    Proc Natl Acad Sci U S A; 1991 Jun; 88(11):4621-5. PubMed ID: 1711204
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The ninth component of complement and the pore-forming protein (perforin 1) from cytotoxic T cells: structural, immunological, and functional similarities.
    Young JD; Cohn ZA; Podack ER
    Science; 1986 Jul; 233(4760):184-90. PubMed ID: 2425429
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Homology of perforin to the ninth component of complement (C9).
    Shinkai Y; Takio K; Okumura K
    Nature; 1988 Aug; 334(6182):525-7. PubMed ID: 3261391
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structural/functional similarity between proteins involved in complement- and cytotoxic T-lymphocyte-mediated cytolysis.
    Tschopp J; Masson D; Stanley KK
    Nature; 1986 Aug 28-Sep 3; 322(6082):831-4. PubMed ID: 2427956
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The heparin binding domain of S-protein/vitronectin binds to complement components C7, C8, and C9 and perforin from cytolytic T-cells and inhibits their lytic activities.
    Tschopp J; Masson D; Schäfer S; Peitsch M; Preissner KT
    Biochemistry; 1988 May; 27(11):4103-9. PubMed ID: 2458130
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cloning, analysis, and expression of murine perforin 1 cDNA, a component of cytolytic T-cell granules with homology to complement component C9.
    Lowrey DM; Aebischer T; Olsen K; Lichtenheld M; Rupp F; Hengartner H; Podack ER
    Proc Natl Acad Sci U S A; 1989 Jan; 86(1):247-51. PubMed ID: 2783486
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Perforin. A family of killer proteins.
    Stanley K; Luzio P
    Nature; 1988 Aug; 334(6182):475-6. PubMed ID: 3261390
    [No Abstract]   [Full Text] [Related]  

  • 9. Primary sequence homology between the effector molecules that mediate complement and T-lymphocyte cytotoxicity.
    Lowrey DM; Rupp F; Aebischer T; Grey P; Hengartner H; Podack ER
    Ann Inst Pasteur Immunol; 1987; 138(2):296-300. PubMed ID: 3496905
    [No Abstract]   [Full Text] [Related]  

  • 10. Localization and molecular modelling of the membrane-inserted domain of the ninth component of human complement and perforin.
    Peitsch MC; Amiguet P; Guy R; Brunner J; Maizel JV; Tschopp J
    Mol Immunol; 1990 Jul; 27(7):589-602. PubMed ID: 2395434
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Membrane channel formation by the lymphocyte pore-forming protein: comparison between susceptible and resistant target cells.
    Persechini PM; Young JD; Almers W
    J Cell Biol; 1990 Jun; 110(6):2109-16. PubMed ID: 1693622
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of the lytic activity of perforin (cytolysin) and of late complement components by proteoglycans.
    Tschopp J; Masson D
    Mol Immunol; 1987 Sep; 24(9):907-13. PubMed ID: 3498887
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structure and function of human perforin.
    Lichtenheld MG; Olsen KJ; Lu P; Lowrey DM; Hameed A; Hengartner H; Podack ER
    Nature; 1988 Sep; 335(6189):448-51. PubMed ID: 3419519
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pore formers of the immune system.
    Podack ER; Deyev V; Shiratsuchi M
    Adv Exp Med Biol; 2007; 598():325-41. PubMed ID: 17892222
    [No Abstract]   [Full Text] [Related]  

  • 15. Structure and activity of the N-terminal region of the eukaryotic cytolysin equinatoxin II.
    Drechsler A; Potrich C; Sabo JK; Frisanco M; Guella G; Dalla Serra M; Anderluh G; Separovic F; Norton RS
    Biochemistry; 2006 Feb; 45(6):1818-28. PubMed ID: 16460028
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Solution structure of a synthetic lytic peptide: the perforin amino terminus.
    Natarajan K; Cowan JA
    Chem Biol; 1998 Mar; 5(3):147-54. PubMed ID: 9545423
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-idiotypic antibodies derived against C8, C9 and perforin bind homologous restriction factor.
    Young JD; Jiang S; Liu CC; Hasselkus-Light CS
    J Immunol Methods; 1990 Mar; 128(1):133-42. PubMed ID: 1691232
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human perforin (PRF1) maps to 10q22, a region that is syntenic with mouse chromosome 10.
    Fink TM; Zimmer M; Weitz S; Tschopp J; Jenne DE; Lichter P
    Genomics; 1992 Aug; 13(4):1300-2. PubMed ID: 1505959
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The pore-forming protein (perforin) of cytolytic T lymphocytes is immunologically related to the components of membrane attack complex of complement through cysteine-rich domains.
    Young JD; Liu CC; Leong LG; Cohn ZA
    J Exp Med; 1986 Dec; 164(6):2077-82. PubMed ID: 3537195
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Binding of human complement C8 to C9: role of the N-terminal modules in the C8 alpha subunit.
    Scibek JJ; Plumb ME; Sodetz JM
    Biochemistry; 2002 Dec; 41(49):14546-51. PubMed ID: 12463754
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.